filmov
tv
Adjuvant chemo omission feasible for certain postmenopausal breast cancer patients | Kevin Kalinsky
Показать описание
Kevin Kalinsky presents the SWOG S1007 RxPONDER trial suggesting that menopausal status could help guide adjuvant chemotherapy use in women with early-stage, HR-positive breast cancer and a low genomic recurrence score (5:15).
0:05:14
0:00:28
0:46:31
0:00:43
0:23:21
0:05:00
0:36:42
0:06:52
0:31:33
0:02:05
0:02:24
0:25:22
0:03:23
0:02:11
0:02:33
0:03:16
0:45:31
0:05:34
1:02:03
0:05:24
0:01:19
0:33:42
1:41:54
0:05:32